Sales of over-the-counter indigestion remedies will grow over 28%between 1997 and 2001, according to a new report from Euromonitor, which points out that this is much faster than any other sector of the world OTC health care market, for which growth of 20% is forecast over this period.
While showing the fastest growth, digestive remedies will remain the smallest OTC category, with 1997 sales of $7.5 billion moving up to $9.6 billion in 2001.
The largest segment, dietary supplements, had 1997 turnover of $10.8 billion, with 17.9% growth pushing this up to $12.7 billion by 2001. Medicated skin care products will increase 20.5% from $9.6 billion to $11.6 billion, cough and cold remedies will grow 17.1% from $9.1 billion to $10.7 billion, and analgesics will expand 17.1% from $8.7 billion of $10.1 billion, says Euromonitor.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze